跳至主要内容
临床试验/NCT03423693
NCT03423693已完成不适用

Comparative Study on Sputum Anti-inflammatory Mediators in Patients With Asthma or Asthma and COPD Overlap (ACOS) Syndrome, and COPD

Mahidol University1 个研究点 分布在 1 个国家目标入组 230 人开始时间: 2018年1月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
230
试验地点
1
主要终点
Lipoxin A4, ,

研究概览

简要总结

This study was designed as retrospective chart review to test our hypothesis whether there are the differences in inflammatory and anti-inflammatory mediators between asthmatic and ACOS patients with small airway obstruction, and COPD

详细描述

The data including spirometry, lung volume, impulse oscillometry, sputum data, demographic characters within 6 months are collected for later analysis. Sputum supernatants and cytospins are used to determine inflammatory and anti-inflammatory responses in those patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Physician-diagnosed asthma, ACO, and COPD
  • Their spirometric, IOS, lung volume, demographic data and sputum samples are available

排除标准

  • Concomitant diseases requiring immunosuppressive therapy
  • Being on treatments with NSAIDs, macrolides, statins

结局指标

主要结局

Lipoxin A4, ,

时间窗: 1 day (single time point)

Lipoxin A4 is measured in sputum supernatants by ELISA

次要结局

  • IL-33(1 day (single time point))
  • Thymic stromal lymphopoietin (TSLP)(1 day (single time point))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kittipong Maneechotesuwan

Professor

Mahidol University

研究点 (1)

Loading locations...

相似试验

Small Airway Obstruction in Asthma, COPD, ACOS | 临床试验